Structure of the human Papillomavirus E7 oncoprotein and its mechanism for inactivation of the retinoblastoma tumor suppressor (Q24292803)

https://api.crossref.org/works/10.1074%2FJBC.M508455200

Human papillomavirus and cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508455200

Papillomaviruses and cancer: from basic studies to clinical application

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508455200

The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508455200

The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508455200

The human papillomavirus type 16 E7 gene encodes transactivation and transformation functions similar to those of adenovirus E1A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508455200

The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508455200

Role of the LXCXE binding site in Rb function

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508455200

Dimerization of the human papillomavirus E7 oncoprotein in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508455200

The HPV16 E7 viral oncoprotein self-assembles into defined spherical oligomers

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508455200

Inhibition of CDK activity and PCNA-dependent DNA replication by p21 is blocked by interaction with the HPV-16 E7 oncoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508455200

Human papillomavirus type 16 E7 binds to the conserved carboxy-terminal region of the TATA box binding protein and this contributes to E7 transforming activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508455200

The E7 oncoprotein associates with Mi2 and histone deacetylase activity to promote cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508455200

Interaction of the HPV E7 proteins with the pCAF acetyltransferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508455200

Human papillomavirus type 16 E7 binds to E2F1 and activates E2F1-driven transcription in a retinoblastoma protein-independent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508455200

A revised picture of the E2F transcriptional network and RB function

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508455200

Chromatin remodeling and Rb activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508455200

Principles of tumor suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508455200

Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508455200

Identification of a growth suppression domain within the retinoblastoma gene product

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508455200

Protein Domains Governing Interactions Between E2F, the Retinoblastoma Gene Product, and Human Papillomavirus type 16 E7 Protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508455200

Crystal structure of the retinoblastoma tumor suppressor protein bound to E2F and the molecular basis of its regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508455200

Structure of the retinoblastoma tumour-suppressor pocket domain bound to a peptide from HPV E7

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508455200

Automated MAD and MIR structure solution

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508455200

Maximum-likelihood density modification

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508455200

Automated main-chain model building by template matching and iterative fragment extension

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508455200

Crystallography & NMR System: A New Software Suite for Macromolecular Structure Determination

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508455200

Improved methods for building protein models in electron density maps and the location of errors in these models

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508455200

Refinement of macromolecular structures by the maximum-likelihood method

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508455200

PROCHECK: a program to check the stereochemical quality of protein structures

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508455200

Three regions of the pRB pocket domain affect its inactivation by human papillomavirus E7 proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508455200

Structural basis for the recognition of the E2F transactivation domain by the retinoblastoma tumor suppressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508455200

Dual Mechanisms for the Inhibition of E2F Binding to RB by Cyclin-Dependent Kinase-Mediated RB Phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508455200

Mechanisms by which DNA tumor virus oncoproteins target the Rb family of pocket proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508455200

Down regulation of the interleukin-8 promoter by human papillomavirus type 16 E6 and E7 through effects on CREB binding protein/p300 and P/CAF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508455200

Interaction between the HPV E7 oncoprotein and the transcriptional coactivator p300

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508455200

The binding of histone deacetylases and the integrity of zinc finger-like motifs of the E7 protein are essential for the life cycle of human papillomavirus type 31.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508455200

Oligomerization properties of the viral oncoproteins adenovirus E1A and human papillomavirus E7 and their complexes with the retinoblastoma protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508455200

7 January 2021

Acetylation control of the retinoblastoma tumour-suppressor protein

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508455200

7 January 2021

The E6-E7 region of human papillomavirus type 18 is sufficient for transformation of NIH 3T3 and rat-1 cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508455200

7 January 2021

The human papillomavirus E7 oncoprotein and the cellular transcription factor E2F bind to separate sites on the retinoblastoma tumor suppressor protein.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508455200

7 January 2021

Identifiers

DOI

10.1074/JBC.M508455200

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

16249186

1 reference

Consolidated OpenCitations Corpus – April 2017